1. A clean environmental week: Let the nature breathe
    Khaled Moustafa, 2017, Science of The Total Environment CrossRef
  2. Emerging landscape of circular RNAs in lung cancer
    Wei Hu et al, 2018, Cancer Letters CrossRef
  3. Therapeutic potential of combined BRAF/MEK blockade in BRAF-wild type preclinical tumor models
    Anais Del Curatolo et al, 2018, J Exp Clin Cancer Res CrossRef
  4. Characterization of germline mutations in familial lung cancer from the Chinese population
    Madiha Kanwal et al, 2018, Gene CrossRef
  5. CircRNA fibroblast growth factor receptor 3 promotes tumor progression in non-small cell lung cancer by regulating Galectin-1-AKT/ERK1/2 signaling
    Bai-Quan Qiu et al, 2018, J Cell Physiol CrossRef
  6. Cyclophilin B promotes cell proliferation, migration, invasion and angiogenesis via regulating the STAT3 pathway in non-small cell lung cancer
    Mao-rong Teng et al, 2019, Pathology - Research and Practice CrossRef
  7. Alternative splicing in lung cancer
    Alice O. Coomer et al, 2019, Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms CrossRef
  8. New discoveries of mdig in the epigenetic regulation of cancers.
    Qian Zhang et al, 2019, Semin Cancer Biol CrossRef
  9. Surgical Treatment of Lung Cancer
    Haley Hoy et al, 2019, Critical Care Nursing Clinics of North America CrossRef
  10. Quantifying the Potential for Future Gene Therapy to Lower Lifetime Risk of Polygenic Late-Onset Diseases
    Roman Teo Oliynyk, 2019, IJMS CrossRef
  11. Evaluating the Potential of Younger Cases and Older Controls Cohorts to Improve Discovery Power in Genome-Wide Association Studies of Late-Onset Diseases
    Roman Teo Oliynyk, 2019, JPM CrossRef
  12. Lung Cancer Mortality in China
    Ning Wang et al, 2019, Chest CrossRef
  13. Propensity score analysis of lung cancer risk in a population with high prevalence of non-smoking related lung cancer.
    Kuei-Feng Lin et al, 2017, BMC Pulm Med CrossRef
  14. null
    Timothy Craig Allen, 2018 CrossRef
  15. Polysaccharide-enhanced ARGET ATRP signal amplification for ultrasensitive fluorescent detection of lung cancer CYFRA 21-1 DNA
    Xia Wang et al, 2020, Anal Bioanal Chem CrossRef
  16. Radon Biomonitoring and microRNA in Lung Cancer
    Rakhmet Bersimbaev et al, 2020, IJMS CrossRef
  17. Clinical significance of circulating tumor cells and metabolic signatures in lung cancer after surgical removal
    Dawei Yang et al, 2020, J Transl Med CrossRef
  18. MicroRNA-296, a suppressor non-coding RNA, downregulates SGLT2 expression in lung cancer
    Xiaotian Zhang et al, 2018, Int J Oncol CrossRef
  19. Plk1 promotes the migration of human lung adenocarcinoma epithelial cells via STAT3 signaling
    Weijuan Yan et al, 2018, Oncol Lett CrossRef
  20. Validity of an NGS‑based multiple gene panel in identifying actionable mutations for patients with NSCLC in a Chinese hospital
    Wei Cao et al, 2019, Oncol Lett CrossRef
  21. Association between family history of lung cancer and lung cancer risk: a systematic review and meta-analysis
    Lina Ang et al, 2020, Lung Cancer CrossRef
  22. New Target Therapies in Advanced Non-Small Cell Lung Cancer: A Review of the Literature and Future Perspectives
    Ramon Andrade de Mello et al, 2020, JCM CrossRef
  23. Artificial Intelligence Tools for Refining Lung Cancer Screening
    J. Luis Espinoza et al, 2020, JCM CrossRef
  24. Annotation and extraction of age and temporally-related events from clinical histories
    Judy Hong et al, 2020, BMC Med Inform Decis Mak CrossRef
  25. Plausible Role of Estrogens in Pathogenesis, Progression and Therapy of Lung Cancer
    Claudia Musial et al, 2021, IJERPH CrossRef
  26. null
    Amir Mousapasandi et al, 2021 CrossRef
  27. A label-free immunosensor for the detection of a new lung cancer biomarker, GM2 activator protein, using a phosphomolybdic acid/polyethyleneimine coated gold nanoparticle composite
    Kulrisa Kuntamung et al, 2021, Analyst CrossRef
  28. Molecular pathogenesis of hereditary lung cancer: a literature review
    Souraya Rammal et al, 2021, Pharmacogenomics CrossRef
  29. The Role of Family Health History in Predicting Midlife Chronic Disease Outcomes
    Naomi N. Duke et al, 2021, American Journal of Preventive Medicine CrossRef
  30. Biomacromolecule-mediated pulmonary delivery of siRNA and anti-sense oligos: challenges and possible solutions
    Yaseen Hussain et al, 2021, Expert Rev. Mol. Med. CrossRef
  31. Multilocus Inherited Neoplasia Allele Syndrome (MINAS): an update
    Anthony McGuigan et al, 2022, Eur J Hum Genet CrossRef
  32. Lung cancer mortality trends in Mexico, 1998–2018: the impact of the General Law on Tobacco Control
    Juan Alejandro Torres-Domínguez et al, 2022, Rev. bras. epidemiol. CrossRef
  33. Towards Machine Learning-Aided Lung Cancer Clinical Routines: Approaches and Open Challenges
    Francisco Silva et al, 2022, JPM CrossRef
  34. Exosomes as Nanocarriers for Theragnostic miRNA Markers in Nonsmall Cell Lung Cancer Therapy
    Ziyu Jiang et al, 2022, Journal of Nanomaterials CrossRef
  35. Wide Next-Generation Sequencing Characterization of Young Adults Non-Small-Cell Lung Cancer Patients
    Paola Ulivi et al, 2022, Cancers CrossRef
  36. A new approach used in docking study for predicting the combination drug efficacy in EML4-ALK target of NSCLC
    Saleena Younus et al, 2022, Journal of Biomolecular Structure and Dynamics CrossRef
  37. Risk Factors for Lung Cancer in the Province of Lecce: Results from the PROTOS Case–Control Study in Salento (Southern Italy)
    Fabrizio Minichilli et al, 2022, IJERPH CrossRef
  38. Functional studies of lung cancer GWAS beyond association
    Erping Long et al, 2022 CrossRef
  39. Cross-ancestry genome-wide meta-analysis of 61,047 cases and 947,237 controls identifies new susceptibility loci contributing to lung cancer
    Jinyoung Byun et al, 2022, Nat Genet CrossRef
  40. null
    Iago Dillion Lima Cavalcanti, 2022 CrossRef
  41. A mouse model of lung cancer induced via intranasal injection for anticancer drug screening and evaluation of pathology.
    Ryo Tanaka et al, 2023, FEBS Open Bio CrossRef
  42. Construction and case study of a novel lung cancer risk index
    Ali Faghani et al, 2022, BMC Cancer CrossRef
  43. Association of CYP19A1 rs28757157 polymorphism with lung cancer risk in the Chinese Han population
    Chan Zhang et al, 2022, World J Surg Onc CrossRef
  44. Immunotherapeutics in lung cancers: from mechanistic insight to clinical implications and synergistic perspectives
    Hardeep Singh Tuli et al, 2022, Mol Biol Rep CrossRef
  45. The Importance of the Immune System and Molecular Cell Signaling Pathways in the Pathogenesis and Progression of Lung Cancer
    Jolanta Smok-Kalwat et al, 2023, IJMS CrossRef
  46. Label-free electrochemical detection of cancer biomarkers DNA and anti-p53 at tin oxide quantum dot-gold-DNA nanoparticle modified electrode
    Yesurajan Allwin Richard et al, 2023, Bioelectrochemistry CrossRef
  47. Liquid Biopsy for Lung Cancer: Up-to-Date and Perspectives for Screening Programs
    Giovanna Maria Stanfoca Casagrande et al, 2023, IJMS CrossRef
  48. Recent Advances in Lung Cancer Therapy Based on Nanomaterials: A Review
    Leila Gholami et al, 2023, CMC CrossRef
  49. A literature review of microRNA and gene signaling pathways involved in the apoptosis pathway of lung cancer
    Hanie Abolfathi et al, 2023, Respir Res CrossRef
  50. Lung cancer immunotherapy: progress, pitfalls, and promises
    Aritraa Lahiri et al, 2023, Mol Cancer CrossRef
  51. The Role of Pembrolizumab (Keytruda) in Treating Non-small Cell Lung Cancer
    Linwei Ren, 2023, HSET CrossRef
  52. Are calcium channel blockers related to lung cancer?
    Ratchanon Rattanathanoo et al, 2023, dti CrossRef
  53. Lycium barbarum polysaccharide reduces lung cancer immunotherapy-related endocrine adverse reactions and improves prognosis via interleukin-2
    Zhiping Lv et al, 2023, mat express CrossRef
  54. null
    Kawthar Mohamed et al, 2023 CrossRef
  55. Applications of nanotechnology in the treatment of pulmonary diseases
    Rahit Kumar Dey et al, 2023, Vessel Plus CrossRef
  56. null
    Koshy Alexander et al, 2023 CrossRef
  57. Assessing a Polygenic Risk Score for Lung Cancer Susceptibility in Non-Hispanic White and Black Populations
    Matthew R. Trendowski et al, 2023 CrossRef
  58. Insights into the Biological Activity and Cytotoxic Mechanism of Epimedium pubigerum
    Gökçe Seyhan et al, 2023, Chemistry & Biodiversity CrossRef
  59. Design, synthesis and biological evaluation of small molecule fluorescent probes targeting EGFR for tumor detection and treatment
    Depu Song et al, 2023, Analyst CrossRef
  60. Prevalence, patterns, and factors associated with tobacco use among patients with priority tobacco related illnesses at four Kenyan national referral hospitals, 2022
    Valerian Mwenda et al, 2023, PLOS Glob Public Health CrossRef
  61. Regulation and therapeutic potentials of microRNAs to non-small cell lung cancer
    Mai Thi Le et al, 2023, Heliyon CrossRef
  62. PVT1 lncRNA in Lung Cancer: A Key Player in Tumorigenesis and Therapeutic Opportunities
    Mohammed Ageeli Hakami et al, 2023, Pathology - Research and Practice CrossRef
  63. In Vitro Cytotoxicity of Reproductive Stage Withania somnifera Leaf and Stem on HepG2 Cell Line
    Lali Lingfa et al, 2023, Evidence-Based Complementary and Alternative Medicine CrossRef
  64. Risk factors for the development of lung cancer around the world: a review
    Hervé Agonsanou et al, 2023 CrossRef
  65. null
    Koshy Alexander et al, 2024 CrossRef
  66. Promises of Protein Kinase Inhibitors in Recalcitrant Small-Cell Lung Cancer: Recent Scenario and Future Possibilities
    Aniket Tiwari et al, 2024, Cancers CrossRef
  67. Characterization of Incidental Pathogenic Germline Findings Detected via ctDNA among Patients with Non-Small Cell Lung Cancer in a Predominantly Hispanic/Latinx Population
    Esha Vallabhaneni et al, 2024, Cancers CrossRef
  68. Dual-specificity tyrosine-regulated kinase 2 exerts anti-tumor effects by induction of G1 arrest in lung adenocarcinoma
    Eriko Harada et al, 2024, Biochimica et Biophysica Acta (BBA) - General Subjects CrossRef
  69. Exhaled breath condensate contains extracellular vesicles (EVs) that carry miRNA cargos of lung tissue origin that can be selectively purified and analyzed
    Megan I. Mitchell et al, 2024, J of Extracellular Vesicle CrossRef
  70. Low-Dose Computed Tomography Scan and Biopsy for Assessing Lung Cancer Prevalence and Related Factors in High-Risk Populations
    Duy Hoang Tran et al, 2024, Heliyon CrossRef
  71. SMAC Mimetics for the Treatment of Lung Carcinoma: Present Development and Future Prospects
    Ruchi Pandey et al, 2024, MRMC CrossRef
  72. Modification Role of Dietary Antioxidants in the Association of High Red Meat Intake and Lung Cancer Risk: Evidence from a Cancer Screening Trial
    Jiaqi Yang et al, 2024, Antioxidants CrossRef
  73. Pan-cancer analysis and experimental validation reveal FAM72D as a potential novel biomarker and therapeutic target in lung adenocarcinoma
    Zonglang Zhou et al, 2024, Gene CrossRef